Man Group
CVAC

Man Group’s CureVac CVAC Stock Holding History

Man Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,949
Closed -$277K – 2109
2022
Q4 		$277K Sell
45,949
-236,047
-84% -$1.74M ﹤0.01% 1674
2022
Q3 		$2.22M Buy
+281,996
New +$3.29M 0.01% 1028
2022
Q2 		– Hold
0
– – – 1517
2021
Q4 		– Sell
-11,647
Closed -$636K – 1975
2021
Q3 		$636K Buy
+11,647
New +$702K ﹤0.01% 1475
2021
Q1 		– Sell
-4,943
Closed -$401K – 1876
2020
Q4 		$401K Buy
+4,943
New +$378K ﹤0.01% 1596

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Man Group's CVAC Position: Q1 2023 in Review

Man Group sold out of CureVac (CVAC) in Q1 2023, closing a stake of 45,949 shares — an estimated $277K sold.

Man Group first reported a position in CVAC in Q4 2020 and held it in 4 quarters. The position peaked at $2.22M in Q3 2022. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

  • Man Group reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 45,949 CureVac shares in Q1 2023, an estimated $277K.
  • Man Group first reported a position in CureVac in Q4 2020 and held it in 4 quarters.
  • Man Group's CureVac position peaked at $2.22M in Q3 2022.
  • 82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.